Tag: Blood Donor
-
Giving Back to Our Donors: Personalized Blood Pressure Information
The American Red Cross values the generosity of the millions of individuals who donate life-saving blood each year. . Over 46% of US adults have high blood pressure, or hypertension; and many of them are unaware of their medical condition (1). Hypertension may occur alone or with other medical conditions. Most of the time, there…
-
Young Apheresis Platelet Donors Give Hope To The Resiliency Of The US Platelet Supply
Summary provided by Dr. Baia Lasky Platelet demand continues to increase (1) and U.S. hospitals face frequent shortages (2). Between 2010 and 2019, the American Red Cross’ (ARC) platelet distributions increased by 16.6% (778,775 to 907,851 units); therefore, a reliable and sustainable apheresis platelet donor (APD) base is essential to support patient care. . During…
-
Motivating Donors: Lessons from Collecting COVID-19 Convalescent Plasma
Early in the SARS-CoV-2 pandemic, many blood centers began collecting and distributing COVID-19 convalescent plasma (CCP). Researchers from the American Red Cross conducted a survey of CCP donors during the first five months of the CCP collection period (April 27-September 15, 2020) to gather information about their donation experience and motivations. Read about their findings…
-
SPOTLIGHT On LAB WEEK: Red Cross labs advance patient care
Although far from the spotlight, medical laboratory scientists and other laboratory professionals play a vital role in health care and patient outcome. The work of testing, diagnosing, and treatment is crucial in saving lives—but the Red Cross takes laboratory services a step further. Improving patient care through innovation and decades of research lies at the…
-
Making Blood Donation More Inclusive: The ADVANCE Study
In December 2020, the American Red Cross, OneBlood and Vitalant, together representing over 50% of the blood supply in the United States, initiated the ADVANCE (Assessing Donor Variability And New Concepts in Eligibility) Study. ADVANCE was a pilot study funded by a contract from the US Food and Drug Administration (FDA) that could potentially lead…